114 results on '"Harris, Louis S."'
Search Results
2. PHARMACOLOGICAL ACTIVITY OF DELTA-9-THC METABOLITES AND ANALOGS OF CBD, DELTA-8-THC AND DELTA-9-THC
3. COMPARATIVE STUDY OF THE EFFECTS OF TWO NARCOTIC ANTAGONISTS NALOXONE AND NALORPHINE ON DEVELOPING MORPHINE DEPENDENCE IN RHESUS MONKEY
4. SUBCELLULAR DISTRIBUTION OF 3H-Δ9-TETRAHYDROCANNABINOL IN BRAINS OF NONTOLERANT AND TOLERANT RATS
5. INTRAPERITONEAL INFUSION OF NARCOTIC ANTAGONISTS IN RAT
6. A Comparison of the Subcellular Distribution of Cannabinoids in the Brains of Tolerant and Nontolerant Dogs, Rats, and Mice After Injecting Radiolabeled Δ9-Tetrahydrocannabinol
7. ANALGESIC AND PHYSICAL DEPENDENCE LIABILITY OF TWO NEW ESTERS OF N-METHYLPIPERIDINE
8. Analgesic and Antitumor Potential of the Cannabinoids
9. Structure-Activity Relationships
10. Chapter 4. Analgetics — Strong and Weak
11. Narcotic Antagonists as Analgesics
12. Chapter 4. Analgetics–Strong and Weak
13. Chapter 4. Analgetics – Strong and Weak
14. Exploring Pharmacological Activities and Signaling of Morphinans Substituted in Position 6 as Potent Agonists Interacting with the μ Opioid Receptor
15. l-theanine attenuates abstinence signs in morphine-dependent rhesus monkeys and elicits anxiolytic-like activity in mice
16. Fumaroylamino-4,5-epoxymorphinans and Related Opioids with Irreversible μ Opioid Receptor Antagonist Effects
17. MDAN-21: A Bivalent Opioid Ligand Containing mu-Agonist and Delta-Antagonist Pharmacophores and Its Effects in Rhesus Monkeys
18. Introduction of a 6-cyano group in 14-oxygenated N-methylmorphinans influences in vitro and in vivo pharmacological activities
19. Removal of continuous nicotine infusion produces somatic but not behavioral signs of withdrawal in mice
20. Mixed κ/μ Opioid Receptor Agonists: The 6β-Naltrexamines
21. The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans
22. Probes for Narcotic Receptor Mediated Phenomena. 34. Synthesis and Structure−Activity Relationships of a Potent μ-Agonist δ-Antagonist and an Exceedingly Potent Antinociceptive in the Enantiomeric C9-Substituted 5-(3-Hydroxyphenyl)-N-phenylethylmorphan Series
23. Pharmacological studies with a nonpeptidic, delta-opioid (−)-(1R,5R,9R)-5,9-dimethyl-2′-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((−)-NIH 11082)
24. NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action
25. Opioid ligands with mixed properties from substituted enantiomeric N-phenethyl-5-phenylmorphans. Synthesis of a µ-agonist δ-antagonist and δ-inverse agonists
26. Effects of JDTic, a selective κ-opioid receptor antagonist, on the development and expression of physical dependence on morphine using a rat continuous-infusion model
27. Effect of a 6-Cyano Substituent in 14-Oxygenated N-Methylmorphinans on Opioid Receptor Binding and Antinociceptive Potency
28. Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist
29. Discriminative Stimulus, Reinforcing, Physical Dependence, and Antinociceptive Effects of Oxycodone in Mice, Rats, and Rhesus Monkeys.
30. Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 21. Novel 4-Alkoxy and 14-Phenylpropoxy Derivatives of the μ Opioid Receptor Antagonist Cyprodime
31. Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 20. 14-Phenylpropoxymetopon: An Extremely Powerful Analgesic
32. Synthesis and Biological Evaluation of 14-Alkoxymorphinans. 18. N-Substituted 14-Phenylpropyloxymorphinan-6-ones with Unanticipated Agonist Properties: Extending the Scope of Common Structure−Activity Relationships
33. N-(Trifluoromethyl)benzyl substituted N-Normetazocines and N-Norketobemidones
34. A memorial tribute to Dr Leo E. Hollister (1920–2000)
35. Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats
36. Synthesis and in Vitro and in Vivo Activity of (−)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-Alkenyl-, -N-Alkynyl-, and -N-Cyanoalkyl-5,9-dimethyl-2‘-hydroxy-6,7-benzomorphan Homologues
37. Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat
38. N-cyclohexylethyl-N-noroxymorphindole: a μ-Opioid preferring analogue of naltrindole
39. Stereoselective μ- and δ-opioid receptor-related antinociception and binding with (+)-thebaine
40. Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain
41. 3-Alkyl Ethers of Clocinnamox: Delayed Long-Term μ-Antagonists with Variable μ Efficacy
42. Evaluation of the discriminative stimulus and reinforcing effects of dihydroetorphine
43. Etorphines: μ-opioid receptor-selective antinociception and low physical dependence capacity
44. Potent reinforcing effects of dihydroetorphine in rats
45. Problems of Drug Dependence 1996: Proceedings of the 58th Annual Scientific Meeting: The College on Problems of Drug Dependence, Inc: NIDA Research Monograph 174
46. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB)
47. Evaluation of the discriminative stimulus and reinforcing effects of gammahydroxybutyrate (GHB)
48. Problems of Drug Dependence, 1995: Proceedings of the 57th Annual Scientific Meeting, The College on Problems of Drug Dependence, Inc: NIDA Research Monograph 162
49. Evaluation of a series of N-alkyl benzomorphans in cell lines expressing transfected δ- and μ-opioid receptors
50. Toxicological evaluation of μ‐agonists. Part II: Assessment of toxicity following 30 days of repeated oral dosing of male and female rats with levo‐alpha‐noracetylmethadol hcl (norlaam)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.